Eli Lilly’s weight-loss pill didn’t work so well, and the stock is tumbling
Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Posts by MarketWatch
Bank of England committee was so divided there were two interest-rate votes
Bank of England committee was so divided there were two votes on interest rates
U.K. central bank had to hold two votes after a rare, initial 4-4-1 decision.
Dividends rise when companies have confidence about earnings — but this is happening instead
This year’s record-setting pace of share buybacks is bearish.
There are few assets hated like coal — why this dirty fuel may have a future
Is coal making a comeback? The stocks are cheap and demand demise predictions are coming down.
Eli Lilly stock is tumbling after trial data from oral weight-loss drug
‘I’m scared to lose’: I have $140K in a 401(k) and earn $45K a year. Can I retire in 20 years?
“My 401(k) retirement planner shows I’ll likely be short $1,500 every month during my retirement.”
‘She lives alone’: My mother-in-law, 86, gets $1,300 in Social Security. Is that enough to live on?
“We provide housing for her and send her a couple of hundred dollars a month.”
Why this Bernie Sanders housing graphic is a chart crime — and what the real data shows
Even by the data-twisting standards of politicians, Sen. Bernie Sanders’ take on the housing market hits new depths.
More people are late on both their mortgage and student-loan payments — another bad sign for the economy
The trends come at a time when the U.S. economy is showing signs of weakness.